Skip to main content
SpringerLink
Log in

Pediatric and Adolescent Acne

  • Chapter
  • First Online:
Pediatric Skin of Color

  • 1290 Accesses

Abstract

Acne is one of the most common dermatologic concerns in adolescents of all skin types. The incidence of pediatric acne is also increasing with early onsets of adrenarche, especially in certain ethnic groups. Notably, there are some vital differences in the presentation of acne in children and in patients with skin of color. Despite the increasing awareness of acne in skin of color, research in this population, especially in the pediatric age group, is still sparse. Most recommendations are based on expert opinion and small studies. The principles of acne treatment are the same within age groups and skin types, but creating age-appropriate treatment plans and managing the sequelae of acne, hyperpigmentation and scarring can be the most challenging in skin of color patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

P. acnes :

Propionibacterium acnes

DHEAS:

Dehydroepiandrosterone sulfate

FSH:

Follicle-stimulating hormone

LH:

Luteinizing hormone

PCOS:

Polycystic ovary syndrome

SAPHO:

Synovitis, arthritis/acne, palmar pustulosis, hyperostosis, osteitis

PIH:

Postinflammatory hyperpigmentation

EDCs:

Endocrine-disrupting chemicals

BP:

Benzoyl peroxide

SA:

Salicylic acid

AA:

Azelaic acid

CP:

Clindamycin phosphate

DHS:

Drug hypersensitivity

LLS:

Lupus-like syndrome

COCs:

Combined oral contraceptives

SHBG:

Steroid hormone binding globulin

DHT:

Dihydrotestosterone

STIs:

Sexually transmitted infections

DMPA:

Depot medroxyprogesterone acetate

LARC:

Long-acting reversible contraception

DISH:

Diffuse idiopathic skeletal hyperostosis

IBD:

Inflammatory bowel disease

IPL:

Intense pulse light

POMC:

Pro-opiomelanocortin

PDT:

Photodynamic therapy

LPDL:

Long-pulsed dye laser

References

  1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474–85.

    CAS  PubMed  Google Scholar 

  2. Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94.

    PubMed  Google Scholar 

  3. Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol. 2011;25(9):1054–60.

    CAS  PubMed  Google Scholar 

  4. Cheng CE, Irwin B, Mauriello D, Liang L, Pappert A, Kimball AB. Self-reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010;27(5):446–52.

    PubMed  Google Scholar 

  5. Freyre EA, Rebaza RM, Sami DA, Lozada CP. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health. 1998;22(6):480–4.

    CAS  PubMed  Google Scholar 

  6. Yahya H. Acne vulgaris in Nigerian adolescents–prevalence, severity, beliefs, perceptions, and practices. Int J Dermatol. 2009;48(5):498–505.

    PubMed  Google Scholar 

  7. Abad-Casintahan F, Chow SK, Goh CL, Kubba R, Miyachi Y, Noppakun N, et al. Toward evidence-based practice in acne: consensus of an Asian Working Group. J Dermatol. 2011;38(11):1041–8.

    PubMed  Google Scholar 

  8. Goldberg JL, Dabade TS, Davis SA, Feldman SR, Krowchuk DP, Fleischer AB. Changing age of acne vulgaris visits: another sign of earlier puberty? Pediatr Dermatol. 2011;28(6):645–8.

    PubMed  Google Scholar 

  9. Biro FM, Galvez MP, Greenspan LC, Succop PA, Vangeepuram N, Pinney SM, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010;126(3):e583–90.

    PubMed  Google Scholar 

  10. Sorensen K, Aksglaede L, Petersen JH, Juul A. Recent changes in pubertal timing in healthy Danish boys: associations with body mass index. J Clin Endocrinol Metab. 2010;95(1):263–70.

    PubMed  Google Scholar 

  11. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics. 2009;123(5):e932–9.

    PubMed  Google Scholar 

  12. Ramnitz MS, Lodish MB. Racial disparities in pubertal development. Semin Reprod Med. 2013;31(5):333–9.

    PubMed  Google Scholar 

  13. Huang B, Biro FM, Dorn LD. Determination of relative timing of pubertal maturation through ordinal logistic modeling: evaluation of growth and timing parameters. J Adolesc Health. 2009;45(4):383–8.

    PubMed Central  PubMed  Google Scholar 

  14. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99(4):505–12.

    CAS  PubMed  Google Scholar 

  15. Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics. 2002;110(4):752–7.

    PubMed  Google Scholar 

  16. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics. 2002;110(4):e43.

    PubMed  Google Scholar 

  17. Davis SA, Sandoval LF, Gustafson CJ, Feldman SR, Cordoro KM. Treatment of preadolescent acne in the United States: an analysis of nationally representative data. Pediatr Dermatol. 2013;30(6):689–94.

    PubMed  Google Scholar 

  18. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18(10):821–32.

    CAS  PubMed  Google Scholar 

  19. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360–6.

    PubMed  Google Scholar 

  20. Richards GM, Oresajo CO, Halder RM. Structure and function of ethnic skin and hair. Dermatol Clin. 2003;21(4):595–600.

    PubMed  Google Scholar 

  21. Warrier AG, Kligman AM, Harper RA, Bowman J, Wickett RR. A comparison of black and white skin using noninvasive methods. J Soc Cosmet Chem. 1996;47:229–40.

    Google Scholar 

  22. Kligman AM, Shelley WB. An investigation of the biology of the human sebaceous gland. J Invest Dermatol. 1958;30(3):99–125.

    CAS  PubMed  Google Scholar 

  23. Pochi PE, Strauss JS. Sebaceous gland activity in black skin. Dermatol Clin. 1988;6(3):349–51.

    CAS  PubMed  Google Scholar 

  24. Grimes P, Edison BL, Green BA, Wildnauer RH. Evaluation of inherent differences between African American and white skin surface properties using subjective and objective measures. Cutis. 2004;73(6):392–6.

    PubMed  Google Scholar 

  25. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002;138(12):1584–90.

    PubMed  Google Scholar 

  26. Silverberg NB. A brief primer on acne therapy for adolescents with skin of color. Cutis. 2013;92(1):20–6.

    PubMed  Google Scholar 

  27. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007;86(1):107–15.

    CAS  PubMed  Google Scholar 

  28. Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;206(1):7–10.

    PubMed  Google Scholar 

  29. Cantatore-Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther. 2006;19(4):202–9.

    PubMed  Google Scholar 

  30. Marcoux D, McCuaig CC, Powell J. Prepubertal acne: clinical presentation, evaluation, and treatment. J Cutan Med Surg. 1998;2 Suppl 3:2–6.

    PubMed  Google Scholar 

  31. Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131 Suppl 3:S163–86.

    PubMed  Google Scholar 

  32. Hello M, Prey S, Leaute-Labreze C, Khammari A, Dreno B, Stalder JF, et al. Infantile acne: a retrospective study of 16 cases. Pediatr Dermatol. 2008;25(4):434–8.

    PubMed  Google Scholar 

  33. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology. 2003;206(1):24–8.

    PubMed  Google Scholar 

  34. Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol. 2001;145(3):463–6.

    CAS  PubMed  Google Scholar 

  35. Kose O, Koc E, Arca E. Adapalene gel 0.1 % in the treatment of infantile acne: an open clinical study. Pediatr Dermatol. 2008;25(3):383–6.

    PubMed  Google Scholar 

  36. Dessinioti C, Katsambas A. Congenital adrenal hyperplasia. Dermatoendocrinology. 2009;1(2):87–91.

    CAS  Google Scholar 

  37. Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr. 1997;130(1):30–9.

    CAS  PubMed  Google Scholar 

  38. Eichenfield LF, Matiz C, Funk A, Dill SW. Study of the efficacy and tolerability of 0.04 % tretinoin microsphere gel for preadolescent acne. Pediatrics. 2010;125(6):e1316–23.

    PubMed  Google Scholar 

  39. Eichenfield LF, Hebert AA, Schachner L, Paller AS, Rossi AB, Lucky AW. Tretinoin microsphere gel 0.04 % pump for treating acne vulgaris in preadolescents: a randomized, controlled study. Pediatr Dermatol. 2012;29(5):598–604.

    PubMed  Google Scholar 

  40. Eichenfield LF, Draelos Z, Lucky AW, Hebert AA, Sugarman J, Stein Gold L, et al. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides. J Drugs Dermatol. 2013;12(6):611–8.

    CAS  PubMed  Google Scholar 

  41. Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S98–106.

    Google Scholar 

  42. Wilkins Jr JW, Voorhees JJ. Prevalence of nodulocystic acne in white and Negro males. Arch Dermatol. 1970;102(6):631–4.

    PubMed  Google Scholar 

  43. Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24–38.

    PubMed Central  PubMed  Google Scholar 

  44. Poli F. Differential diagnosis of facial acne on black skin. Int J Dermatol. 2012;51 Suppl 1:24–6, 7–9.

    Google Scholar 

  45. Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol. 1998;37(10):772–7.

    CAS  PubMed  Google Scholar 

  46. Poli F. Acne on pigmented skin. Int J Dermatol. 2007;46 Suppl 1:39–41.

    PubMed  Google Scholar 

  47. Grimes PE, Stockton T. Pigmentary disorders in blacks. Dermatol Clin. 1988;6(2):271–81.

    CAS  PubMed  Google Scholar 

  48. Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48(6 Suppl):S143–8.

    PubMed  Google Scholar 

  49. Andersen KE, Maibach HI. Black and white human skin differences. J Am Acad Dermatol. 1979;1(3):276–82.

    CAS  PubMed  Google Scholar 

  50. Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–95.

    PubMed  Google Scholar 

  51. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18(1):91–8, ix.

    Google Scholar 

  52. Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43(5):362–5.

    PubMed  Google Scholar 

  53. Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S41–62.

    Google Scholar 

  54. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg. 2009;28(2):71–6.

    CAS  PubMed  Google Scholar 

  55. El-Essawi D, Musial JL, Hammad A, Lim HW. A survey of skin disease and skin-related issues in Arab Americans. J Am Acad Dermatol. 2007;56(6):933–8.

    PubMed  Google Scholar 

  56. Spann CT. Ten tips for treating acne vulgaris in Fitzpatrick skin types IV-VI. J Drugs Dermatol. 2011;10(6):654–7.

    PubMed  Google Scholar 

  57. Goodman G. Cleansing and moisturizing in acne patients. Am J Clin Dermatol. 2009;10 Suppl 1:1–6.

    PubMed  Google Scholar 

  58. Draelos ZD. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne. Cutis. 2006;78(1 Suppl):34–40.

    PubMed  Google Scholar 

  59. Toombs EL. Cosmetics in the treatment of acne vulgaris. Dermatol Clin. 2005;23(3):575–81, viii.

    Google Scholar 

  60. Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol. 1970;101(5):580–4.

    CAS  PubMed  Google Scholar 

  61. James-Todd T, Terry MB, Rich-Edwards J, Deierlein A, Senie R. Childhood hair product use and earlier age at menarche in a racially diverse study population: a pilot study. Ann Epidemiol. 2011;21(6):461–5.

    PubMed Central  PubMed  Google Scholar 

  62. Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. 2003;42(4):287–9.

    PubMed  Google Scholar 

  63. Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar. Senegal Br J Dermatol. 2003;148(3):493–500.

    CAS  Google Scholar 

  64. Kombate K, Mouhari-Toure A, Saka B, Akakpo AS, Maboudou A, Pitche P, et al. Acne and skin bleaching in Lome, Togo. Int J Dermatol. 2012;51 Suppl 1:27–9, 30–2.

    Google Scholar 

  65. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1–37.

    PubMed  Google Scholar 

  66. Atralin (tretinoin) Gel, 0.05% [package insert]. Fort Worth, TX: Coria Laboratories.

    Google Scholar 

  67. EPIDUO® (adapalene and benzoylperoxide) Gel 0.1% / 2.5% [package insert]. Fort Worth, TX: Galderma Laboratories, L.P.

    Google Scholar 

  68. Eichenfield LF, Krakowski AC. Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2 % and benzoyl peroxide 2.5 % aqueous gel. J Drugs Dermatol. 2012;11(7):818–24.

    CAS  PubMed  Google Scholar 

  69. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl):S200–10.

    PubMed  Google Scholar 

  70. Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1–50.

    PubMed  Google Scholar 

  71. Kawashima M, Harada S, Loesche C, Miyachi Y. Adapalene gel 0.1 % is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study. J Dermatol Sci. 2008;49(3):241–8.

    CAS  PubMed  Google Scholar 

  72. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139 Suppl 52:8–11.

    CAS  PubMed  Google Scholar 

  73. Czernielewski J, Poncet M, Mizzi F. Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris. Cutis. 2002;70(4):243–8.

    PubMed  Google Scholar 

  74. Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:37–42.

    PubMed  Google Scholar 

  75. Jacyk WK, Mpofu P. Adapalene gel 0.1 % for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 Suppl):48–54.

    CAS  PubMed  Google Scholar 

  76. Tu P, Li GQ, Zhu XJ, Zheng J, Wong WZ. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:31–6.

    PubMed  Google Scholar 

  77. Saple DG, Torsekar RG, Pawanarkar V, Dhanalakshmi UR, Ravichandran G, Kaur D, et al. An open study to evaluate the efficacy and safety of tazarotene gel (0.1 %) in acne vulgaris. Indian J Dermatol Venereol Leprol. 2004;70(2):92–5.

    CAS  PubMed  Google Scholar 

  78. Kligman AM. Acne vulgaris: tricks and treatments. Part II: The benzoyl peroxide saga. Cutis. 1995;56(5):260–1.

    CAS  PubMed  Google Scholar 

  79. Kligman AM, Leyden JJ, Stewart R. New uses for benzoyl peroxide: a broad-spectrum antimicrobial agent. Int J Dermatol. 1977;16(5):413–7.

    CAS  PubMed  Google Scholar 

  80. Hegemann L, Toso SM, Kitay K, Webster GF. Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol. 1994;130(5):569–75.

    CAS  PubMed  Google Scholar 

  81. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1 % and benzoyl peroxide 2.5 % for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(9):899–905.

    PubMed  Google Scholar 

  82. Shalita AR, Rafal ES, Anderson DN, Yavel R, Landow S, Lee WL. Compared efficacy and safety of tretinoin 0.1 % microsphere gel alone and in combination with benzoyl peroxide 6 % cleanser for the treatment of acne vulgaris. Cutis. 2003;72(2):167–72.

    PubMed  Google Scholar 

  83. Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6 %. Cutis. 2008;82(6):417–21.

    PubMed  Google Scholar 

  84. Mohd Nor NH, Aziz Z. A systematic review of benzoyl peroxide for acne vulgaris. J Dermatolog Treat. 2013;24(5):377–86.

    CAS  PubMed  Google Scholar 

  85. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O'Neill C, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364(9452):2188–95.

    CAS  PubMed  Google Scholar 

  86. Nakada T, Hostynek JJ, Maibach HI. Use tests: ROAT (repeated open application test)/PUT (provocative use test): an overview. Contact Dermatitis. 2000;43(1):1–3.

    CAS  PubMed  Google Scholar 

  87. Leyden JJ. Efficacy of benzoyl peroxide (5.3 %) emollient foam and benzoyl peroxide (8 %) wash in reducing Propionibacterium acnes on the back. J Drugs Dermatol. 2010;9(6):622–5.

    PubMed  Google Scholar 

  88. Shalita AR. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clin Ther. 1989;11(2):264–7.

    CAS  PubMed  Google Scholar 

  89. Milstone EB, McDonald AJ, Scholhamer Jr CF. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol. 1981;117(3):154–5.

    CAS  PubMed  Google Scholar 

  90. Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol. 1986;122(5):583–4.

    CAS  PubMed  Google Scholar 

  91. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol. 2000;43(2 Pt 3):S47–50.

    CAS  PubMed  Google Scholar 

  92. Gollnick HP, Graupe K, Zaumseil RP. Azelaic acid 15 % gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges. 2004;2(10):841–7.

    PubMed  Google Scholar 

  93. Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439 e1–10.

    Google Scholar 

  94. Raimer S, Maloney JM, Bourcier M, Wilson D, Papp K, Siegfried E, et al. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis. 2008;81(2):171–8.

    PubMed  Google Scholar 

  95. Gold LS. Efficacy and tolerability of fixed-combination acne treatment in adolescents. Cutis. 2013;91(3):152–9.

    PubMed  Google Scholar 

  96. Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for the Treatment of Acne and Acne-induced Post-inflammatory Hyperpigmentation in Patients with Skin of Color. J Clin Aesthet Dermatol. 2012;5(7):25–32.

    PubMed Central  PubMed  Google Scholar 

  97. Epiduo® gel becomes first topical prescription acne treatment available for children as young as 9 years old. Fort Worth, TX: PRNewswire; 2013 [cited 2014 February 24]. http://www.prnewswire.com/news-releases/epiduo-gel-becomes-first-topical-prescription-acne-treatment-available-for-children-as-young-as-9-years-old-191807741.html

  98. Fleischer Jr AB, Dinehart S, Stough D, Plott RT. Safety and efficacy of a new extended-release formulation of minocycline. Cutis. 2006;78(4 Suppl):21–31.

    PubMed  Google Scholar 

  99. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(6 Suppl): 9–25.

    PubMed  Google Scholar 

  100. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust. 1998;169(5):259–61.

    CAS  PubMed  Google Scholar 

  101. Bjellerup M, Ljunggren B. Double blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers. Photodermatology. 1987;4(6):281–7.

    CAS  PubMed  Google Scholar 

  102. Valean S, Petrescu M, Catinean A, Chira R, Mircea PA. Pill esophagitis. Rom J Gastroenterol. 2005;14(2):159–63.

    PubMed  Google Scholar 

  103. Kadayifci A, Gulsen MT, Koruk M, Savas MC. Doxycycline-induced pill esophagitis. Dis Esophagus. 2004;17(2):168–71.

    CAS  PubMed  Google Scholar 

  104. Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis. 2000;66(4 Suppl):7–13.

    PubMed  Google Scholar 

  105. Del Rosso JQ. Clinical significance of brand versus generic formulations: focus on oral minocycline. Cutis. 2006;77(3):153–6.

    PubMed  Google Scholar 

  106. Tsankov N, Broshtilova V, Kazandjieva J. Tetracyclines in dermatology. Clin Dermatol. 2003;21(1):33–9.

    PubMed  Google Scholar 

  107. Knowles SR, Shear NH. Recognition and management of severe cutaneous drug reactions. Dermatol Clin. 2007;25(2):245–53, viii.

    Google Scholar 

  108. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol. 1997;133(10):1224–30.

    CAS  PubMed  Google Scholar 

  109. Geria AN, Tajirian AL, Kihiczak G, Schwartz RA. Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat. 2009;17(2):123–6.

    PubMed  Google Scholar 

  110. Gordon G, Sparano BM, Iatropoulos MJ. Hyperpigmentation of the skin associated with minocycline therapy. Arch Dermatol. 1985;121(5):618–23.

    CAS  PubMed  Google Scholar 

  111. Treister NS, Magalnick D, Woo SB. Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(6):718–25.

    PubMed  Google Scholar 

  112. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6(1):29–37.

    PubMed  Google Scholar 

  113. Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998;126(1):116–21.

    CAS  PubMed  Google Scholar 

  114. Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne vulgaris: practical considerations for the clinician based on current data and clinical experience. J Clin Aesthet Dermatol. 2012;5(3):37–50.

    PubMed Central  CAS  PubMed  Google Scholar 

  115. Kim GK, Michaels BB. Post-adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol. 2012;11(6):708–13.

    PubMed  Google Scholar 

  116. Thiboutot D, Chen W. Update and future of hormonal therapy in acne. Dermatology. 2003;206(1):57–67.

    PubMed  Google Scholar 

  117. George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg. 2008;27(3):188–96.

    CAS  PubMed  Google Scholar 

  118. Tremblay MR, Luu-The V, Leblanc G, Noel P, Breton E, Labrie F, et al. Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities. Bioorg Med Chem. 1999;7(6):1013–23.

    CAS  PubMed  Google Scholar 

  119. Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009;22(5):452–7.

    PubMed  Google Scholar 

  120. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001;285(17):2232–9.

    CAS  PubMed  Google Scholar 

  121. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health. 2011;20(1):5–10.

    Google Scholar 

  122. Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2011;9, CD003987.

    PubMed  Google Scholar 

  123. Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. 2003;70(8):681–90.

    PubMed  Google Scholar 

  124. Lloyd T, Rollings N, Andon MB, Demers LM, Eggli DF, Kieselhorst K, et al. Determinants of bone density in young women: relationships among pubertal development, total body bone mass, and total body bone density in premenarchal females. J Clin Endocrinol Metab. 1992;75(2):383–7.

    CAS  PubMed  Google Scholar 

  125. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril. 2008;90(6):2060–7.

    PubMed Central  PubMed  Google Scholar 

  126. Lloyd T, Petit MA, Lin HM, Beck TJ. Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr. 2004;144(6):776–82.

    PubMed  Google Scholar 

  127. Kelly AP, Sampson DD. Recalcitrant nodulocystic acne in black Americans: treatment with isotretinoin. J Natl Med Assoc. 1987;79(12):1266–70.

    PubMed Central  CAS  PubMed  Google Scholar 

  128. Gan EY, Koh WP, Jin AZ, Tan AW, Tan HH, Tang MB. Isotretinoin is safe and efficacious in Asians with acne vulgaris. J Dermatolog Treat. 2013;24(5):387–91.

    CAS  PubMed  Google Scholar 

  129. Ventura SJ, Abma JC, Mosher WD, Henshaw SK. Estimated pregnancy rates for the United States, 1990-2005: an update. Natl Vital Stat Rep. 2009;58(4):1–14.

    Google Scholar 

  130. Lavin C, Cox JE. Teen pregnancy prevention: current perspectives. Curr Opin Pediatr. 2012;24(4):462–9.

    PubMed  Google Scholar 

  131. Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, et al. Youth risk behavior surveillance—United States, 2011. MMWR Surveill Summ. 2012;61(4):1–162.

    PubMed  Google Scholar 

  132. Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Schootman M, Bucholz KK, Peipert JF, et al. Age of sexual debut among US adolescents. Contraception. 2009;80(2):158–62.

    PubMed Central  PubMed  Google Scholar 

  133. Okazaki S. Influences of culture on Asian Americans’ sexuality. J Sex Res. 2002;39(1):34–41.

    PubMed  Google Scholar 

  134. Entezari-Maleki T, Hadjibabaie M, Dousti S, Salamzadeh J, Hayatshahi A, Javadi MR, et al. Evaluation and monitoring of isotretinoin use in Iran. Arch Iran Med. 2012;15(7):409–12.

    PubMed  Google Scholar 

  135. Trussell J. Contraceptive efficacy. In: Hatcher RA, editor. Contraceptive technology. 19th rev. ed. New York, NY: Ardent Media; 2007.

    Google Scholar 

  136. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404.

    PubMed Central  PubMed  Google Scholar 

  137. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998–2007.

    CAS  PubMed  Google Scholar 

  138. Ellis CN, Pennes DR, Martel W, Voorhees JJ. Radiographic bone surveys after isotretinoin therapy for cystic acne. Acta Derm Venereol. 1985;65(1):83–5.

    CAS  PubMed  Google Scholar 

  139. Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ. Isotretinoin therapy is associated with early skeletal radiographic changes. J Am Acad Dermatol. 1984;10(6):1024–9.

    CAS  PubMed  Google Scholar 

  140. Pennes DR, Ellis CN, Madison KC, Voorhees JJ, Martel W. Early skeletal hyperostoses secondary to 13-cis-retinoic acid. AJR Am J Roentgenol. 1984;142(5):979–83.

    CAS  PubMed  Google Scholar 

  141. Carey BM, Parkin GJ, Cunliffe WJ, Pritlove J. (15) DISH and DISH-like syndrome in patients treated with isotretinoin. Br J Dermatol. 1987;117(S32):39.

    Google Scholar 

  142. Ling TC, Parkin G, Islam J, Seukeran DC, Cunliffe WJ. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol. 2001;144(3):630–2.

    CAS  PubMed  Google Scholar 

  143. Stobaugh DJ, Deepak P, Ehrenpreis ED. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. J Am Acad Dermatol. 2013;69(3):393–8.

    PubMed  Google Scholar 

  144. On SC, Zeichner J. Isotretinoin updates. Dermatol Ther. 2013;26(5):377–89.

    PubMed  Google Scholar 

  145. Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2010;105(9):1986–93.

    PubMed Central  PubMed  Google Scholar 

  146. Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol. 2009;104(11):2774–8.

    CAS  PubMed  Google Scholar 

  147. Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2610–6.

    CAS  PubMed  Google Scholar 

  148. Patton GC, Coffey C, Romaniuk H, Mackinnon A, Carlin JB, Degenhardt L, et al. The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study. Lancet. 2014;383(9926):1404–11.

    PubMed  Google Scholar 

  149. Hull PR, D’Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol. 2003;4(7):493–505.

    PubMed  Google Scholar 

  150. Miranda R, Shaffer D. Understanding the suicidal moment in adolescence. Ann N Y Acad Sci. 2013;1304:14–21.

    PubMed  Google Scholar 

  151. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2007;26(4):210–20.

    CAS  PubMed  Google Scholar 

  152. Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol. 2007;14(2):e227–33.

    PubMed  Google Scholar 

  153. Kaymak Y, Taner E, Taner Y. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol. 2009;48(1):41–6.

    CAS  PubMed  Google Scholar 

  154. McGrath EJ, Lovell CR, Gillison F, Darvay A, Hickey JR, Skevington SM. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms. Br J Dermatol. 2010;163(6):1323–9.

    CAS  PubMed  Google Scholar 

  155. Rehn LM, Meririnne E, Hook-Nikanne J, Isometsa E, Henriksson M. Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts. J Eur Acad Dermatol Venereol. 2009;23(11):1294–7.

    CAS  PubMed  Google Scholar 

  156. Dreno B, Fischer TC, Perosino E, Poli F, Viera MS, Rendon MI, et al. Expert opinion: efficacy of superficial chemical peels in active acne management–what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol. 2011;25(6):695–704.

    CAS  PubMed  Google Scholar 

  157. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18–22.

    CAS  PubMed  Google Scholar 

  158. Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006;32(3):372–5. discussion 5.

    CAS  PubMed  Google Scholar 

  159. Roberts WE. Chemical peeling in ethnic/dark skin. Dermatol Ther. 2004;17(2):196–205.

    PubMed  Google Scholar 

  160. Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20(5):266–9.

    PubMed  Google Scholar 

  161. Yeung CK, Shek SY, Yu CS, Kono T, Chan HH. Treatment of inflammatory facial acne with 1,450-nm diode laser in type IV to V Asian skin using an optimal combination of laser parameters. Dermatol Surg. 2009;35(4):593–600.

    CAS  PubMed  Google Scholar 

  162. Noborio R, Nishida E, Morita A. Clinical effect of low-energy double-pass 1450 nm laser treatment for acne in Asians. Photodermatol Photoimmunol Photomed. 2009;25(1):3–7.

    PubMed  Google Scholar 

  163. Kawana S, Tachihara R, Kato T, Omi T. Effect of smooth pulsed light at 400 to 700 and 870 to 1,200 nm for acne vulgaris in Asian skin. Dermatol Surg. 2010;36(1):52–7.

    PubMed  Google Scholar 

  164. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is its role? Am J Clin Dermatol. 2004;5(4):211–6.

    PubMed  Google Scholar 

  165. Terrell S, Aires D, Schweiger ES. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient. J Drugs Dermatol. 2009;8(7):669–71.

    PubMed  Google Scholar 

  166. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol. 2001;144(3):575–9.

    CAS  PubMed  Google Scholar 

  167. Hong SB, Lee MH. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. 2005;21(6):322–5.

    CAS  PubMed  Google Scholar 

  168. Eimpunth S, Wanitphadeedecha R, Manuskiatti W. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians. J Eur Acad Dermatol Venereol. 2013;27 Suppl 1:7–18.

    PubMed  Google Scholar 

  169. Jang H, Koo FK, Ke L, Clemson L, Cant R, Fraser DR, et al. Culture and sun exposure in immigrant East Asian women living in Australia. Women Health. 2013;53(5):504–18.

    PubMed  Google Scholar 

  170. Gorell E, Lee C, Munoz C, Chang AL. Adoption of Western culture by Californian Asian Americans: attitudes and practices promoting sun exposure. Arch Dermatol. 2009;145(5):552–6.

    PubMed  Google Scholar 

  171. Yoshimura K, Harii K, Aoyama T, Iga T. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg. 2000;105(3):1097–108. discussion 109–10.

    CAS  PubMed  Google Scholar 

  172. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438–43.

    CAS  PubMed  Google Scholar 

  173. Hoshaw RA, Zimmerman KG, Menter A. Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121(1):105–8.

    CAS  PubMed  Google Scholar 

  174. Weiss RM, del Fabbro E, Kolisang P. Cosmetic ochronosis caused by bleaching creams containing 2 % hydroquinone. S Afr Med J. 1990;77(7):373.

    CAS  PubMed  Google Scholar 

  175. Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613–22.

    CAS  PubMed  Google Scholar 

  176. Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis. 1996;57(1 Suppl):36–45.

    CAS  PubMed  Google Scholar 

  177. Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15 % in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10(6):586–90.

    CAS  PubMed  Google Scholar 

  178. Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatolog Treat. 2010;21(3):206–11.

    PubMed  Google Scholar 

  179. Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.

    PubMed  Google Scholar 

  180. Orlow SJ, Chakraborty AK, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol. 1990;94(4):461–4.

    CAS  PubMed  Google Scholar 

  181. Geria AN, Lawson CN, Halder RM. Topical retinoids for pigmented skin. J Drugs Dermatol. 2011;10(5):483–9.

    CAS  PubMed  Google Scholar 

  182. Kircik LH. Tretinoin microsphere gel pump 0.04 % versus tazarotene cream 0.05 % in the treatment of mild-to-moderate facial acne vulgaris. J Drugs Dermatol. 2009;8(7):650–4.

    PubMed  Google Scholar 

  183. Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45–50.

    PubMed  Google Scholar 

  184. Stratigos AJ, Katsambas AD. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients. Am J Clin Dermatol. 2004;5(3):161–8.

    PubMed  Google Scholar 

  185. Godse K, Sakhia J. Triple combination and glycolic peels in post-acne hyperpigmentation. J Cutan Aesthet Surg. 2012;5(1):60–1.

    PubMed Central  PubMed  Google Scholar 

  186. Kurita M, Kato H, Yoshimura K. A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians. J Plast Reconstr Aesthet Surg. 2009;62(7):955–63.

    PubMed  Google Scholar 

  187. Nordlund JJ. Postinflammatory hyperpigmentation. Dermatol Clin. 1988;6(2):185–92.

    CAS  PubMed  Google Scholar 

  188. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45(1):109–17.

    CAS  PubMed  Google Scholar 

  189. Ho SG, Yeung CK, Chan NP, Shek SY, Kono T, Chan HH. A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med. 2011;43(1):1–7.

    CAS  PubMed  Google Scholar 

  190. Kim S, Cho KH. Treatment of procedure-related postinflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence in Asian patients: report of five cases. J Cosmet Dermatol. 2010;9(4):302–6.

    PubMed  Google Scholar 

  191. Lee HS, Lee JH, Ahn GY, Lee DH, Shin JW, Kim DH, et al. Fractional photothermolysis for the treatment of acne scars: a report of 27 Korean patients. J Dermatolog Treat. 2008;19(1):45–9.

    CAS  PubMed  Google Scholar 

  192. Paller A, Mancini AJ, Hurwitz S. Hurwitz clinical pediatric dermatology. 4th ed. Edinburgh; New York: Elsevier Saunders; 2011. 624p.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Penn State/Hershey Medical Center, Hershey, PA, USA

    Charlene Lam MD, MPH

  2. Departments of Dermatology and Pediatrics, Penn State/Hershey Medical Center, 500 University Drive HU14, Hershey, PA, 17033, USA

    Andrea L. Zaenglein MD

Authors
  1. Charlene Lam MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea L. Zaenglein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea L. Zaenglein MD .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Mt. Sinai St. Luke’s-Roosevelt Hospital and Beth Israel Medical centers, New York, New York, USA

    Nanette B. Silverberg

  2. Department of Pediatric Dermatology, National Institute of Pediatrics, Mexico City, Mexico

    Carola Durán-McKinster

  3. Department of Dermatology, Changi General Hospital, Singapore, Singapore

    Yong-Kwang Tay

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lam, C., Zaenglein, A.L. (2015). Pediatric and Adolescent Acne. In: Silverberg, N., Durán-McKinster, C., Tay, YK. (eds) Pediatric Skin of Color. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6654-3_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6654-3_38

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6653-6

  • Online ISBN: 978-1-4614-6654-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation